These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 889154

  • 1. Intradermal administration of bivalent and monovalent influenza vaccines.
    Brooks JH, Criep LH, Ruben FL.
    Ann Allergy; 1977 Aug; 39(2):110-2. PubMed ID: 889154
    [Abstract] [Full Text] [Related]

  • 2. Use of an inhibitor-resistant live attenuated influenza vaccine in normal and asthmatic adults.
    Warshauer DM, Minor TE, Inhorn SL, Reed CE, Dick EC.
    Dev Biol Stand; 1976 Aug; 33():184-90. PubMed ID: 782967
    [Abstract] [Full Text] [Related]

  • 3. Persistence of influenza serum antibodies in humans following immunization with a bivalent A/Victoria and A/New Jersey vaccine.
    Boucher DW, Contreras G, Furesz J.
    Can Med Assoc J; 1979 Apr 07; 120(7):799-802, 831. PubMed ID: 427686
    [Abstract] [Full Text] [Related]

  • 4. Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination.
    Sugimura T, Ito Y, Tananari Y, Ozaki Y, Maeno Y, Yamaoka T, Kudo Y.
    Vaccine; 2008 May 23; 26(22):2700-5. PubMed ID: 18436353
    [Abstract] [Full Text] [Related]

  • 5. Experience with monovalent and bivalent influenza vaccines in Canada 1976. Clinical evaluation of vaccines from four sources.
    Johnson SE, Pearson EW.
    Dev Biol Stand; 2008 May 23; 39():267-72. PubMed ID: 342309
    [Abstract] [Full Text] [Related]

  • 6. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.
    Van Damme P, Oosterhuis-Kafeja F, Van der Wielen M, Almagor Y, Sharon O, Levin Y.
    Vaccine; 2009 Jan 14; 27(3):454-9. PubMed ID: 19022318
    [Abstract] [Full Text] [Related]

  • 7. Clinical reactions and serologic responses after vaccination with whole-virus or split-virus influenza vaccines in children aged 6 to 36 months.
    Bernstein DI, Zahradnik JM, DeAngelis CJ, Cherry JD.
    Pediatrics; 1982 Apr 14; 69(4):404-8. PubMed ID: 7070886
    [Abstract] [Full Text] [Related]

  • 8. Impaired serum antibody response to inactivated influenza A and B vaccine in cancer patients.
    Stiver HG, Weinerman BH.
    Can Med Assoc J; 1978 Oct 07; 119(7):733,-5, 738. PubMed ID: 709474
    [Abstract] [Full Text] [Related]

  • 9. Serologic responses and systemic reactions in adults after vaccination with bivalent A/Victoria/75-A/New Jersey/76 and monovalent B/Hong Kong/72 influenza vaccines.
    Wise TG, Dolin R, Mazur MH, Top FH, Edelman R, Ennis FA.
    J Infect Dis; 1977 Dec 07; 136 Suppl():S507-17. PubMed ID: 342623
    [Abstract] [Full Text] [Related]

  • 10. Immunogenicity and safety of intradermal versus intramuscular route of influenza immunization in infants less than 6 months of age: a randomized controlled trial.
    Chiu SS, Chan KH, Tu W, Lau YL, Peiris JS.
    Vaccine; 2009 Jul 30; 27(35):4834-9. PubMed ID: 19523908
    [Abstract] [Full Text] [Related]

  • 11. Human responses to purified surface antigen invluenza vaccine (Fluvirin).
    Stones PB, Furminger IG, Kerr J.
    Dev Biol Stand; 2009 Jul 30; 39():239-42. PubMed ID: 604103
    [Abstract] [Full Text] [Related]

  • 12. Serological response to an adsorbed killed trivalent influenza vaccine (including A/New Jersey 8/76 antigen).
    Sarateanu D, Ehrengut W, Pressler K.
    Dev Biol Stand; 2009 Jul 30; 39():235-8. PubMed ID: 604102
    [Abstract] [Full Text] [Related]

  • 13. [Prevalence of antibodies to A/New Jersey/76, A/Victoria/3/75 and B/Hong Kong/5/72 influenza viruses in the population of Milan examined in the late spring of 1976 and evaluation of the past experience of the same population with probable agent of the 1918-20 pandemics].
    Profeta ML, Ferrante P.
    Boll Ist Sieroter Milan; 1976 Sep 30; 55(4):272-8. PubMed ID: 1016579
    [Abstract] [Full Text] [Related]

  • 14. Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages.
    Camilloni B, Neri M, Lepri E, Iorio AM.
    Vaccine; 2009 Jun 24; 27(31):4099-103. PubMed ID: 19410623
    [Abstract] [Full Text] [Related]

  • 15. Live attenuated influenza virus vaccines in patients with chronic broncho-pulmonary diseases. Clinical and immunological evaluation.
    Prevost JM, Vereerstraeten-Schmerber J, Lamy F, De Koster JP.
    Scand J Respir Dis; 1975 May 24; 56(1):58-69. PubMed ID: 1096297
    [Abstract] [Full Text] [Related]

  • 16. Responses of elderly subjects to monovalent A/USSR/77 (H1N1) and Trivalent A/USSR/77 (H1N1)-A/TEXAS/77 (H3N2)-B/Hong Kong/72 vaccines.
    Brandriss MW, Betts RF, Mathur U, Douglas RG.
    Am Rev Respir Dis; 1981 Dec 24; 124(6):681-4. PubMed ID: 7316272
    [Abstract] [Full Text] [Related]

  • 17. Comparison of one- and two-dose regimens of influenza vaccine for elderly men.
    Levine M, Beattie BL, McLean DM.
    CMAJ; 1987 Oct 15; 137(8):722-6. PubMed ID: 3651943
    [Abstract] [Full Text] [Related]

  • 18. Antibody responses after dose-sparing intradermal influenza vaccination.
    Auewarakul P, Kositanont U, Sornsathapornkul P, Tothong P, Kanyok R, Thongcharoen P.
    Vaccine; 2007 Jan 08; 25(4):659-63. PubMed ID: 17011678
    [Abstract] [Full Text] [Related]

  • 19. [Influenza vaccination in dialysis patients].
    Haldimann B, Descoeudres C.
    Schweiz Med Wochenschr; 1978 Jan 14; 108(2):52-5. PubMed ID: 622534
    [Abstract] [Full Text] [Related]

  • 20. Influenza surveillance of Wisconsin (USA) population-detection of A/New Jersey by isolation and serologic monitoring and vaccine evaluation.
    Nelson DB, Inhorn SL.
    Dev Biol Stand; 1978 Jan 14; 39():429-36. PubMed ID: 342315
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.